Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidemiology Study Using the French Health Care Claims Database
NCT06902441
·
clinicaltrials.gov ↗
COMPLETED
Status
52000
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Sponsor
University Hospital, Caen